The PROPHECY trial: Multicenter prospective trial of circulating tumor cell (CTC) AR-V7 detection in men with mCRPC receiving abiraterone (A) or enzalutamide (E).

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Armstrong, AJ; Halabi, S; Luo, J; Nanus, DM; Giannakakou, P; Szmulewitz, RZ; Danila, DC; Healy, P; Anand, M; Rothwell, C; Silberstein, J; Galletti, G; Somarelli, J; Gupta, S; Gregory, S; Scher, HI; Dittamore, R; Tagawa, ST; Antonarakis, ES; George, DJ

Published Date

  • May 20, 2018

Published In

Volume / Issue

  • 36 / 15_suppl

Start / End Page

  • 5004 - 5004

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2018.36.15_suppl.5004